VistaGen Therapeutics, Inc.

NasdaqCM:VTGN Stock Report

Mkt Cap: US$47.3m

VistaGen Therapeutics Company Information

VistaGen Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: VistaGen Therapeutics, Inc.
  • Ticker: VTGN
  • Exchange: NasdaqCM
  • Founded: 1998
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$47.345m
  • Shares outstanding: 206.84m
  • Website: https://www.vistagen.com

Number of Employees


Location

  • VistaGen Therapeutics, Inc.
  • 343 Allerton Avenue
  • South San Francisco
  • California
  • 94080
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VTGNNasdaqCM (Nasdaq Capital Market)YesNew Common StockUSUSDMay 2011

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/31 00:00
End of Day Share Price2023/01/30 00:00
Earnings2022/09/30
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.